65 related articles for article (PubMed ID: 11807227)
1. Trans-complementation of a genetic defect in the coxsackie B3 virus 2B protein.
van Kuppeveld FJM; van den Hurk PJJC; Schrama IWJ; Galama JMD; Melchers WJG
J Gen Virol; 2002 Feb; 83(Pt 2):341-350. PubMed ID: 11807227
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B: a moderate degree of hydrophobicity is required for a cis-acting function in viral RNA synthesis.
van Kuppeveld FJ; Galama JM; Zoll J; Melchers WJ
J Virol; 1995 Dec; 69(12):7782-90. PubMed ID: 7494289
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis of the coxsackie B3 virus 2B/2C cleavage site: determinants of processing efficiency and effects on viral replication.
van Kuppeveld FJ; van den Hurk PJ; Zoll J; Galama JM; Melchers WJ
J Virol; 1996 Nov; 70(11):7632-40. PubMed ID: 8892883
[TBL] [Abstract][Full Text] [Related]
4. Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication.
van Kuppeveld FJ; Galama JM; Zoll J; van den Hurk PJ; Melchers WJ
J Virol; 1996 Jun; 70(6):3876-86. PubMed ID: 8648724
[TBL] [Abstract][Full Text] [Related]
5. Chimeric coxsackie B3 virus genomes that express hybrid coxsackievirus-poliovirus 2B proteins: functional dissection of structural domains involved in RNA replication.
van Kuppeveld FJ; van den Hurk PJ; van der Vliet W; Galama JM; Melchers WJ
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1833-40. PubMed ID: 9266977
[TBL] [Abstract][Full Text] [Related]
6. Structure-function analysis of coxsackie B3 virus protein 2B.
Van kuppeveld FJ; Melchers WJ; Kirkegaard K; Doedens JR
Virology; 1997 Jan; 227(1):111-8. PubMed ID: 9007064
[TBL] [Abstract][Full Text] [Related]
7. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release.
van Kuppeveld FJ; Hoenderop JG; Smeets RL; Willems PH; Dijkman HB; Galama JM; Melchers WJ
EMBO J; 1997 Jun; 16(12):3519-32. PubMed ID: 9218794
[TBL] [Abstract][Full Text] [Related]
9. Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD.
Florez de Sessions P; Dobrikova E; Gromeier M
J Virol; 2007 Aug; 81(16):8396-405. PubMed ID: 17537861
[TBL] [Abstract][Full Text] [Related]
10. Intragenomic complementation of a 3AB mutant in dicistronic polioviruses.
Cao X; Wimmer E
Virology; 1995 Jun; 209(2):315-26. PubMed ID: 7778266
[TBL] [Abstract][Full Text] [Related]
11. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication.
Liu WJ; Chen HB; Khromykh AA
J Virol; 2003 Jul; 77(14):7804-13. PubMed ID: 12829820
[TBL] [Abstract][Full Text] [Related]
13. Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5'-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth.
Zell R; Klingel K; Sauter M; Fortmüller U; Kandolf R
Virus Res; 1995 Dec; 39(2-3):87-103. PubMed ID: 8837877
[TBL] [Abstract][Full Text] [Related]
14. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
[TBL] [Abstract][Full Text] [Related]
15. [Enterovirus sequencing as a new approach to the laboratory diagnosis for clinical and epidemiological purposes].
Rainetová P; Jiřincová H; Musílek M; Nováková L; Vodičková I; Štruncová V; Švecová M; Pazdiora P; Piskunová N; Trubač P; Zajíc T; Havlíčková M
Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):102-6. PubMed ID: 26099615
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.
Kümmerer BM; Rice CM
J Virol; 2002 May; 76(10):4773-84. PubMed ID: 11967294
[TBL] [Abstract][Full Text] [Related]
17. Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis.
Willian S; Tracy S; Chapman N; Leser S; Romero J; Shapiro B; Currey K
Arch Virol; 2000; 145(10):2061-86. PubMed ID: 11087092
[TBL] [Abstract][Full Text] [Related]
18. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
[TBL] [Abstract][Full Text] [Related]
19. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
Zaini Z; Phuektes P; McMinn P
Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis and genetic analysis of the antigenically related swine vesicular disease virus and coxsackie viruses.
Marquardt O; Ohlinger VF
J Virol Methods; 1995 Jun; 53(2-3):189-99. PubMed ID: 7673387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
